Upgrade to SI Premium - Free Trial

Thermo Fisher Scientific (TMO) PT Raised to $664 at RBC Capital, 'Recovery on Track'

July 24, 2024 12:39 PM
RBC Capital analyst Conor McNamara raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $664.00 (from $660.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles